NURIX THERAPEUTICS, INC. (NRIX) Total liabilities 2019–2025
NURIX THERAPEUTICS, INC. (NRIX) total liabilities at each fiscal year-end, per SEC filings.
$149.4MFY2025 · since FY2019: $53.6M → $149.4M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $149.4M | +4.9% |
| FY2024 | $142.3M | -8.2% |
| FY2023 | $155.1M | +37.2% |
| FY2022 | $113.1M | -15.9% |
| FY2021 | $134.5M | +26.8% |
| FY2020 | $106.1M | +98.0% |
| FY2019 | $53.6M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More NRIX financial trends
NRIX RevenueNRIX Net incomeNRIX Net marginNRIX Gross profitNRIX Gross marginNRIX Operating incomeNRIX Operating marginNRIX Operating cash flowNRIX Free cash flowNRIX Capital expendituresNRIX Return on equityNRIX Stock buybacksNRIX Dividends paidNRIX Total assetsNRIX Shareholders’ equityNRIX overview →